SPAC YHN Acquisition I Limited (YHNAU.US) is listed in the United States and jointly launched by Yonghe Capital and Nuoqi Capital team.

date
19/09/2024
avatar
GMT Eight
Recently, Yonghe Capital and Norquick Capital stated that the new Special Purpose Acquisition Company (SPAC) YHN Acquisition I Limited, jointly initiated by their team, has successfully listed on Nasdaq with the code YHNAU.US. YHN's oversubscription was nearly double, raising a total of $60 million. Yonghe Capital Group Limited is a comprehensive investment enterprise founded by Mr. Lin Bingsheng, the founder of the globally renowned restaurant chain "Yonghe Doujiang", Mr. Feng Zhengming, a prominent financial investor and former Managing Director of Softbank (China) Capital, and Ms. Yuan Kaidi, a seasoned investor. The headquarters is located in Hong Kong, China. Yonghe Capital focuses on investing in outstanding high-growth and healthy industry enterprises in various stages of investment, including early, growth, and late stages. Yonghe Capital views listing as the starting point for invested and incubated enterprises, utilizing the advanced SPAC listing model, which features fast timelines, low costs, simple processes, and stable financing, providing significant advantages for both investors and target companies. Norquick Capital is committed to providing professional services related to SPAC initiation and listing, merger and acquisition, IPO consulting, and has practical experience in both the US and Hong Kong SPAC markets, providing one-stop services for domestic companies seeking overseas listings. Mr. Wang Ganwen, the founder and chairman of Norquick Capital, is widely recognized in the media and industry as the "Asian SPAC Godfather", due to his involvement with several well-known US SPACs. In 2014, he participated in the initiation of DT Asia Investments Limited, the first Asian SPAC to list in the US after the 2008 financial crisis. He later became a founder of Tottenham Acquisitions Limited, which completed a merger with the US biotech company Clene Nanomedicine Inc. in December 2020.

Contact: contact@gmteight.com